Table Of Content

Clin. Lab. Haem. 2001, 23, 419-424 Author Index to Volume 23 Aboud, M.R. & Ma, D.D.F. Increased incidence of venous Balasubramaniam, J., Phelan, L. & Bain, B.J. Evaluation thrombosis in patients with shortened activated partial of a new screening test for sickle cell haemoglobin, thromboplastin times and low ratios for activated 379 protein C resistance, 411 Bandiera, S. see Pafumi, C. Abramova, D. see Froom, P. Barak, M. see Froom, P. Acar, H., Caliskan, U., Kaynak, M., Selman Yildirim, M. & Barberi, I. see Rigoli, L. Largaespada, D.A. Hyperdiploid karyotype in a Child- Bardy, P. see Hui, C.H. hood MDS patient, 255 Bareford, D. see Blann, A.D. Aggio, M.C. see Roque, M.E. Bar-El, M. see Froom, P. Ahsan, G. see Kazmi, M.A. Barnett, D., Goodfellow, K., Ginnever, J., Granger, V., Aleem, A. & Murray, J.A. Spherocytosis preceding the Whitby, L. & Reilly, J.T. Low level leucocyte counting: development of myelodysplasia, 249 a critical variable in the validation of leucodepleted Alessio, K. see Rigoli, L. blood transfusion components as highlighted by an \liberti, G., Proietta, M., Pulignano, I., Di Giovanni, C., external quality assessment study, 43 Tritapepe, L. & Vercillo, G. Respiratory changes in Beard, M.E.J., Potter, H.C., Spearing, R.L. & Brennan, S.O. human red cells, 361 Haemoglobin Pierre-Benite — a high affinity variant Almawi, W.Y. see Irani-Hakime, N. associated with relative polycythaemia, 407 Amendola, G. see Danise, P. Beddall, A. see Munro, R. Anagnostou, D. see Christopoulos, C. Bell, D. see Rose, P. Anastasiadis, G. see Christopoulos, C. Bentley, S. Plus ca change, 69 Andres, E., Kurtz, J.-E., Maloisel, F. & Dufour, P. Otological Berliner, S. see Rotstein, R. manifestations of acute leukaemia: report of two cases Bertesi, M. see Marietta, M. and review of literature, 57 Besson, I. see Oelschlaegel, U. Antico, F. see Giacomini, A. Bigelow, N.C. see Mundee, Y. Antovic, J., S6derstrém, J., Karlman, B. & Blomback, M. Blann, A.D. & Bareford, D. Factors influencing the Evaluation of a new immunoturbidimetric test (Liatest~ frequency of attendance at a warfarin dosing clinic, 205 antithrombin III) for determination of antithrombin Blau, I.W. see Gleissner, B. antigen, 313 Blombick, M. see Antovic, J. Arber, N. see Rotstein, R. Blum, M. see Silverberg, D.S. Arnoulet, C. see Oelschlaegel, U. Bowles, K.M., Tooze, R. & Marcus, R.E. An unusual late Athanassiou, G. see Symeonidis, A. relapse, 197 Attias, D. see Margalit, M. Brennan, S.O. see Beard, M.E.]. Attias, E. see Margalit, M. Brugnara, C. see Danise, P. Au, W.Y. see Leung, K.F.S. Bux, Y. see Oelschlaegel, U. Avitzour, D. see Rotstein, R. Cabello, P. see Krsnik, I. Bailie, K.E.M. see Mcmullin, M.F. Cachia, P.G. see Hepburn, M.D. Bain, B.J. see Balasubramaniam, J. Caliskan, U. see Acar, H. Calogero, A.E. see Pafumi, C. Carli, P.M. see Girodon, F. “Due to a pagination numbering error in this volume, two articles Carmel, R., Vasireddy H., Aurangzeb I., George K., High ‘Concomitant angioimmunoblastic T-cell lymphoma and low grade serum cobalamin levels in the clinical setting — clinical B-cell lymphoproliferative disorder’ by C. Christopoulos, A. Tassidou, S. Golfinopoulou, G. Anastasiadis, $. Manetas & D. Anagnostou associations and holo-transcobalamin changes, 365 (Issue 2) and ‘Molecular abnormalities in B-cell chronic lymphocytic Caruso, R.A. see Rigoli, L. leukaemia’ by C. Fegan (Issue 3) begin on page 139. As a result all Castelli, I. see Marietta, M. associated keywords in the subject index and the entries in the author index related to these papers have been labelled Issue 2 or Issue 3 to Cetin, M. see Uckan, D. identify their source. Chan, A.Y.Y. see Leung, K.F.S. 2001 Blackwell Science Limited ry Author Index to Volume 23 Chan, A.Y.Y. see Ma, S.K. Froom, P., Abramova, D., Bar-El, M. & Barak, M. Reliability Chan, L.C. see Leung, K.F.S. of delayed prothrombin time INR determinations in a Chan, L.C. see Ma, S.K. central laboratory using off-site blood sampling, 189 Chang, Y.H. see Hur, M. Fujimoto, K. see Jiang, M. Charoulakis, N.Z. see Papadaki, H.A. Fusman, R. see Rotstein, R. Chen, L. see Yang, Z.-W. Child, J.A. see Follows, G.A. Gao, X. see Peng, L. Chiu, E.K.W. see Ma, S.K. Garcia Suarez, J. see Krsnik, I. Cho, H.I. see Hur, M. Gessoni, G. see Giacomini, A. Christopoulos, C., Tassidou, A., Golfinopoulou, S., Anast- Ghosh, K. see Shetty, S. asiadis, G., Manetas, S. & Anagnostou, D. Concomitant Giacomini, A., Legovini, P., Gessoni, G., Antico, F., angioimmunoblastic T-cell lymphoma and low grade Valverde, S., Salvadego, M.M. & Manoni, F. Platelet B-cell lymphoproliferative disorder, 139 (Issue 2)* count and parameters determined by the Bayer Chui, D.H.K. see Leung, K.F.S. ADIVA'™ 120 in reference subjects and patients, 181 Cianci, A. see Pafumi, C. Giardina, P. see Pafumi, C. Cohen, S. see Rotstein, R. Ginnever, J. see Barnett, D. Cumming, A.M. see Keeney, S. Giovanni, C.Di see Aliberti, G. Girodon, F., Favre, B., Carli, P.M., Nash, N., Desbiolles, N.., Danise, P., Amendola, G., Nobili, B., Perrotta, S., Miraglia Tatou, E. & Maynadié, M. Minor dysplastic changes are del Giudice, E.., Matarese, S.M.R., Iolascon, A. & frequently observed in the bone marrow aspirate in Brugnara, C. Flow-cytometric analysis of erythrocytes elderly patients without haematological disease, 297 and reticulocytes in congenital dyserythropoietic anae- Gleissner, B.., Blau, I.W., Sindram, A., Reinhardt, R., mia type II (CDA II): value in differential diagnosis with Knauf, W. & Thiel, E. Analysis of chimerism during the hereditary spherocytosis, 7 early period after allogeneic peripheral stem cell trans- Davenport, A. see Rose, P. plantation, 401 Davis, B.H. see Mundee, Y. Golfinopoulou, S. see Christopoulos, C. De Schouwer, P. see Van den Bossche, J. Goodfellow, K. see Barnett, D. Desbiolles, N. see Girodon, F. Granger, V. see Barnett, D. Devreese, K. see Van den Bossche, J. Grech, H. see Rose, P. Donaldson, A., Thomas, P., Serjeant, B.E. & Serjeant, G.R. Green, E.S. see Rose, P. Foetal haemoglobin in homozygous sickle cell disease: Gulley, M.L. Molecular Basis of Cancer, 2nd edition, 417 a study of patients with low HBF levels, 285 Dorward, N. see Munro, R. Hardy, J. see Kendall, R.G. Dufour, P. see Andrés, E. Hassan, R. see Zaidi, Y. Hastings, M. see Zaidi, Y. Ehninger, G. see Oelschlaegel, U. Hendrick, A. Purpuric rash following treatment with Eliopoulos, D.G. see Papadaki, H.A. 2-chlorodeoxyadenosine, 67 Eliopoulos, G.D. see Papadaki, H.A. Hepburn, M.D., Nagesh, K., Heppleston, A.D., Cachia, P.G. Elstein, D. see Margalit, M. & Pippard, M.J. Timing of the appearance of multi- potential and committed haemopoietic progenitors in Facchinetti, F. see Marietta, M. peripheral blood after mobilization in patients with Farina, M. see Pafumi, C. lymphoma, 119 Favre, B. see Girodon, F. Heppleston, A.D. see Hepburn, M.D. Fegan, C. Molecular abnormalities in B-cell chronic Hics6nmez, G. see Uckan, D. ymphocytic leukaemia, 139 (Issue 3)’ Hoffmann, J.J.M.L. EDTA-induced pseudo-neutropenia Fegan, C. see Rose, P. resolved with kanamycin, 193 Ferro, T. see Krsnik, I. Hormila, P. see Joutsi-Korhonen, L. Fitzsimons, E.J. see Mcilwaine, L.M. Horvath, N. see Hui, C.H. Follows, G.A., Child, J.A. & Smith, G.M. Fast-track referral Hughes, T. see Hui, C.H. system for patients with haematological malignancy, Hui, C.H., Bardy, P., Hughes, T., Horvath, N. & To, L.B. 222 Successful salvage of RAEB/AML relapsing early post III 2001 Blackwell Science Ltd., Clin. Lab. Haem., 23, 419-424 Author Index to Volume 23 Fpy) allograft with FLAG-Ida conditioned mini-allograft: Largaespada, D.A. see Acar, H. a report of two cases, 135 Leahy, M.F. see Tytherleigh, L. Hur, M., Chang, Y.H., Yoon J. H., Lee, D.S., Park, M.H. & Lee, D.S. see Hur, M. Cho, H.I. Immunophenotypic and cytogenetic changes Legovini, P. see Giacomini, A. in acute leukaemia at relapse, 173 Leung, K.F.S., Au, W.Y., Chan, A.Y.Y., Chan, L.C., Waye, J.S., Chui, D.H.K. & Ma, S.K. Haemoglobin Q-Thailand laina, A. see Silverberg, D.S. and hereditary spherocytosis in a Chinese family, 53 Imaida, K. see Shimizu, K. Levartovsky, D. see Rotstein, R. Imoto, S. see Jiang, M. Lewis, M.S. see Munro, R. lolascon, A. see Danise, P. Lewis, S.M. see Morris, L.D. lrani-Hakime, N., Tamim, H., Samaha, H. & Almawi, W.Y. Liu, T. see Peng, L. Prevalence of antibodies against hepatitis C virus among blood donors in Lebanon, 1997-2000, 317 Ma, D.D.F. see Aboud, M.R. Ma, S.K. see Leung, K.F.S. Javela, K. see Joutsi-Korhonen, L. Ma, S.K., Chan, A.Y.Y., Chiu, E.K.W. & Chan, L.C. Jiang, H. see Peng, L. Haemoglobin H disease due to (— — SEA) a-globin gene Jiang, H. see Peng, L. deletion and «2-codon 30 (AGAG) mutation: a family Jiang, M., Saigo, K., Kumagai, S., Imoto, S., Kosaka, Y., study, 325McArdle, B. see Kendall, R.G. Matsumoto, H. & Fujimoto, K. Quantification of red McIlwaine, L.M., Fitzsimons, E.J. & Soutar, R.L. Inappro- blood cell fragmentation by automated haematology priate antidiuretic hormone secretion, abdominal pain analyser XE-2100, 167 and disseminated varicella-zoster virus infection: an Joutsi-Korhonen, L., Javela, K., Hormila, P. & Kekomaki, unusual and fatal triad in a patient 13 months post R. Glycoprotein V-specific platelet-associated antibodies Rituximab and autologous stem cell transplantation, in thrombocytopenic patients, 307 253 Kapatais-Zoumbos, K. see Symeonidis, A. MacLennan, S. & Murphy, M.F. Survey of the use of whole Karlman, B. see Antovic, J. blood in current blood transfusion practice, 391 Kaynak, M. see Acar, H. McMullin, M.F., Young, P.B., Bailie, K.E.M., Savage, G.A., Kazmi, M.A., Ahsan, G. & Schey, S.A. The effects of prior Lappin, T.R.J. & White, R. Homocysteine and methyl- induction therapy with melphalan on subsequent malonic acid as indicators of folate and vitamin B,> peripheral blood progenitor cell transplantation for deficiency in pregnancy, 161 myeloma, 125 Maggi, I. see Pafumi, C. Keeney, S. & Cumming, A.M. The molecular biology of Mahendra, P. see Zaidi, Y. von Willebrand disease, 209 Malfait, R. see Van den Bossche, J. Kekomiki, R. see Joutsi-Korhonen, L. Maloisel, F. see Andrés, E. Kelleher, B.P. see Philpott, N. Mancari, R. see Pafumi, C. Kendall, R.G. Erythropoietin, 71 Manetas, S. see Christopoulos, C. Kendall, R.G., Mellors, I., Hardy, J. & McArdle, B. Patients Mangiafico, L. see Pafumi, C. with pulmonary and cardiac disease show an elevated Manoni, F. see Giacomini, A. proportion of immature reticulocytes, 27 Marcus, R.E. see Bowles, K.M. Knauf, W. see Gleissner, B. Margalit, M., Attias, E., Attias, D., Elstein, D., Zimran, A. & Kosaka, Y. see Jiang, M. Matzner, Y. Effect of ozone on neutrophil function Krsnik, L., Ferro, T., Garcia Suarez, J., Vazquez Mazariego, in vitro, 243 Y. & Cabello, P. Translocation t(4;6)(q21;q27) in a case Marietta, M., Castelli, I., Piccinini, F., Neri, I, Bertesi, M.., Facchinetti, F. & Torelli, G. The PFA-100™ system for of primary thrombocythaemia in transformation, 259 Kumagai, S. see Jiang, M. the assessment of platelet function in normotensive and Kurshid, M. see Zaidi, Y. hypertensive pregnancies, 131 Kurtz, J.-E. see Andrés, E. Matarese, S.M.R. see Danise, P. Kyriazopoulos, V. see Symeonidis, A. Matsumoto, H. see Jiang, M. Matzner, Y. see Margalit, M. La Rosa, M.A. see Rigoli, L. Maynadié, M. see Girodon, F. Lappin, T.R.J. see Mcmullin, M.F. Mellors, I. see Kendall, R.G. © 2001 Blackwell Science Ltd., Clin. Lab. Haem., 23, 419-424 Pd Author Index to Volume 23 Meo, A. see Rigoli, L. Page, T. see Millar, C. Miceli, M.R. see Rigoli, L. Papadaki, H.A., Charoulakis, N.Z., Eliopoulos, D.G., Millar, C., Page, T., Paterson, P.J. & Taylor, C.P.F. MRSA Psyllaki, M. & Eliopoulos, G.D. Patients with non- pyomyositis complicating sickle cell anaemia, 329 immune chronic idiopathic neutropenia syndrome have Miraglia del Giudice, E. see Danise, P. increased splenic volume on ultrasonography, 111 Missirlis, Y. see Symeonidis, A. Parekh, S. see Shetty, S. Mitchell, D.C. see Win, N. Park, M.H. see Hur, M. Mohanty, D. see Shetty, S. Paterson, P.J. see Millar, C. Morris, L.D., Pont, A. & Lewis, $.M. Use ofa new HemoCue Peng, L., Gao, X., Jiang, H., Peng, Z. & Su, J. Laboratory system for measuring haemoglobin at low concentra- evaluation of the Sysmex SE-9500 automated haema- tions, 9] tology analyser, 237 Mundee, Y., Bigelow, N.C., Davis, B.H. & Porter, J.B. Flow Peng, L., Yang, H., Jiang, H., Su, J. & Peng, Z. Automated cytometric method for simultaneous assay of foetal reticulocyte counting using the Sysmex RAM-1, 97 haemoglobin containing red cells, reticulocytes and Peng, L., Yang, J., Yang, H., Peng, Z., Xu, C. & Liu, T. foetal haemoglobin containing reticulocytes, 149 Determination of peripheral blood stem cells by the Munro, R., Dorward, N., Lewis, M.S. & Beddall, A. Sysmex SE-9500, 231 Prothrombin time inhibition detected with recombinant Peng, Z. see Peng, L. but not with conventional thromboplastins in two Peng, Z. see Peng, L. patients with high-titre IgM and moderate-titre IgA Peng, Z. see Peng, L. anticardiolipin antibodies, 61 Pernicone, G. see Pafumi, C. Murphy, M.F. see Maclennan, S. Perrotta, S. see Danise, P. Murphy, P.T. & O’Connor, N. Low risk of central venous Phelan, L. see Balasubramaniam, J. thrombosis with nontunnelled central venous catheters, Philpott, N., Kelleher, B.P., Smith, O.P. & O’Broin, S.D. 187 High serum folates and the simplification of red cell Murray, J. see Zaidi, Y. folate analysis, 15 Murray, J.A. see Aleem, A. Piccinini, F. see Marietta, M. Pippard, M.J. see Hepburn, M.D. Nagesh, K. see Hepburn, M.D. Pont, A. see Morris, L.D. Nash, N. see Girodon, F. Porter, J.B. see Mundee, Y. Naumann, R. see Oelschlaegel, U. Potter, H.C. see Beard, M.E.]. Neri, I. see Marietta, M. Proietta, M. see Aliberti, G. Ng, T. & Tillyer, M.L. Warfarin-induced skin necrosis Psiroyannis, A. see Symeonidis, A. associated with Factor V Leiden and protein S deficien- Psyllaki, M. see Papadaki, H.A. cy, 261 Pulignano, I. see Aliberti, G. Nobili, B. see Danise, P. Nowak, R. see Oelschlaegel, U. Qu, J. see Yang, Z.-W. O'Broin, S.D. see Philpott, N. Reilly, J.T. see Barnett, D. O'Connor, N. see Murphy, P.T. Reinhardt, R. see Gleissner, B. O'Shaughnessy, D. see Rose, P. Ricca, M. see Rigoli, L. Oelschlaegel, U., Besson, I., Arnoulet, C., Sainty, D., Nowak, Rigoli, L., Meo, A., Miceli, M.R., Alessio, K., Caruso, R.A., R., Naumann, R., Bux, Y. & Ehninger, G. A standardized La Rosa, M.A., Salpietro, D.C., Ricca, M. & Barberi, I. flow cytometric method for screening paroxysmal noctur- Molecular analysis of {8-thalassaemia patients in a high nal haemoglobinuria (PNH) measuring CD55 and CD59 incidence area of southern Italy, 373 expression on erythrocytes and granulocytes, 81 Rogowsky, O. see Rotstein, R. Roque, M.E., Sandoval, M.J. & Aggio, M.C. Serum Pafumi, C., Zizza, G., Russo, A.., Farina, M., Pernicone, G., erythropoietin and its relation with soluble transferrin Bandiera, S., Giardina, P., Mangiafico, L., Mancari, R., receptor in patients with different types of anaemia in a Maggi, I., Calogero, A.E. & Cianci, A. Placing the locally defined reference population, 291 newborn on the maternal abdomen increases the Rose, P., Bell, D.., Green, E.S., Davenport, A., Fegan, C., volume of umbilical cord blood collected, 397 Grech, H., O'Shaughnessy, D. & Voke, J. The outcome of 2001 Blackwell Science Ltd., Clin. Lab. Haem., 23, 419-424 Author Index to Volume 23 cn ambulatory DVT management using a multidisciplinary Thiel, E. see Gleissner, B. approach, 301 Thomas, P. see Donaldson, A. Rotstein, R., Fusman, R.., Berliner, S., Levartovsky, D.., Tillyer, M.L. see Ng, T. Rogowsky, O., Cohen, S., Shabtai, E., Shapira, L., To, L.B. see Hui, C.H. Avitzour, D., Arber, N. & Zeltser, D. The feasibility of Tooze, R. see Bowles, K.M. estimating the erythrocyte sedimentation rate within a Torelli, G. see Marietta, M. few minutes by using a simple slide test, 21 Tritapepe, L. see Aliberti, G. Russo, A. see Pafumi, C. Tunc, B. see Uckan, D. Tuncer, M. see Uckan, D. Saigo, K. see Jiang, M. Tvcherleigh, L., Taparia, M. & Leahy, M.F. Detection of Sainty, D. see Oelschlaegel, U. hairy cell leukaemia in blood and bone marrow usin og 5 Salpietro, D.C. see Rigoli, L. multidimensional flow cytometry with CD45-PECy 5 Salvadego, M.M. see Giacomini, A. and SS gating, 385 Samaha, H. see Irani-Hakime, N. Sandoval, M.J. see Roque, M.E. Uckan, D., Hicsénmez, G., Tune, B., Cetin, M., Tezcan, [. & Savage, G.A. see Mcmullin, M.F. Tuncer, M. The analysis of eosinophil and lymphocyte Schey, S.A. see Kazmi, M.A. phenotype following single dose of high-dose methyl- Seal, L.H. see Waters, H.M. prednisolone in two siblings with marked hypereosin- Selman Yildirim, M. see Acar, H. ophilia, ?3 3 Serjeant, B.E. see Donaldson, A. Serjeant, G.R. see Donaldson, A. Valverde, S. see Giacomini, A. Shabtai, E. see Rotstein, R. Van de Vyvere, M. see Van den Bossche, J. Shapira, I. see Rotstein, R. Van den Bossche, J., Devreese, K., Malfait. R.. Van de Shetty, S., Ghosh, K., Parekh, S. & Mohanty, D. Combined Vyvere, M. & de Schouwer, P. Comparison of the factor VIII and IX deficiency in a family, 201 reticulocyte mode of the Abx Pentra 120 Retic, Shimizu, K. & Imaida, K. Metastatic transitional cell Coulter® General-S'™, Sysmex” SE 9500, Abbott CD carcinoma or nonsecretory multiple myeloma?, 67 4000 and Bayer Advia 120 haematology analysers in Silverberg, D.S., Iaina, A., Wexler, D. & Blum, M. The a simultaneous evaluation, 355 pathological consequences of anaemia, 1 Vazquez Mazariego, Y. see Krsnik, I. Sindram, A. see Gleissner, B. Vercillo, G. see Aliberti, G. Smith, G.M. see Follows, G.A. Voke, J. see Rose, P. Smith, O.P. see Philpott, N. Sdderstrom, J. see Antovic, J. Waters, H.M. & Seal, L.H. A systematic approach to the Soutar, R.L. see Mcilwaine, L.M. assessment of erythropoiesis, 27] Spearing, R.L. see Beard, M.E.J. Waye, J.S. see Leung, K.F.S. Su, J. see Peng, L. Wexler, D. see Silverberg, D.S. Su, J.. see Peng, L. Whitby, L. see Barnett, D. Symeonidis, A., Athanassiou, G., Psiroyannis, A., Kyriaz- White, R. see Mcmullin, M.P. opoulos, V., Kapatais-Zoumbos, K., Missirlis, Y. & Win, N. & Mitchell, D.C. Platelet apheresis for digital Zoumbos, N. Impairment of erythrocyte viscoelasticity gangrene due to thrombocytosis in chronic myeloid is correlated with levels of glycosylated haemoglobin in leukaemia, 65 diabetic patients, 103 Xu, C. see Peng, L. lamim, H. see lrani-Hakime, N. Tang, Z. see Yang, Z.-W. Yang, H. see Peng, L. Taparia, M. see Tytherleigh, L. Yang, H. see Peng, L. Tassidou, A. see Christopoulos, C. Yang, J. see Peng, L. Tatou, E. see Girodon, F. Yang, S.-H. see Yang, Z.-W. Taylor, C.P.F. see Millar, C. Yang, Z.-W., Yang, S.-H., Chen, L., Qu, J.. Zhu, J. & lezcan, I. see Uckan, D. Tang, Z. Comparison of blood counts in venous, 2001 Blackwell Science Ltd., Clin. Lab. Haem., 23, 419-424 ry Author Index to Volume 23 and arterial blood and their measurement Zhu, J. see Yang, Z.-W. 155 Zimran, A. see Margalit, M. . see Hur, M Zizza, G. see Pafumi, C. , P.B. see Memullin, M.F. Zoumbos, N. see Symeonidis, A. Zaidi, Y., Hastings, M., Murray, J., Hassan, R., Kurshid, M. & Mahendra, P. Quinolone resistance in neutropenic patients: the effect of prescribing policy in the UK and Pakistan, 39 Zeltser, D. see Rotstein, R. 2001 Blackwell Science Ltd Cli] n Lat Haem 23, $19 4 24 Clin. Lab. Haem. 2001, 23, 425-427 Subject Index to Volume 23 abdominal pain 253 CFU-A 119 absolute counting 43 CFU-GM 119 activated partial thromboplastin time 411 chemotaxis 243 acute leukaemia 57, 173 children 33 adhesion 243 chimerism 401 ADVIA™ 120 System 181 chromosome agglutination 193 11 139 (Issue 3)* anaemia 1, 7, 271, 291 13 139 (Issue 3)* anaplastic large-cell 197 chronic 271 angioimmunoblastic disease ] lymphadenopathy 139 (Issue 2)* lymphocytic leukaemia 139 (Issue 3)* lymphoma 139 (Issue 2)* myeloid leukaemia 65 antibodies 317 ciprofloxacin 39 anticardiolipin antibodies 61 cobalamin levels 365 antithrombin antigen 313 codon 30 mutation 325 arterial 155 colbalamin 365 ASO 373 combination 125 ATM 139 (Issue 3)* combined 201 audit 391 complications 187 autoimmune thrombocytopenia 307 congenital spherocytosis 7 automated congestive heart failure 1 analysis 27 CT-scan 57 haematology analyser/s 97, 237, cytogenetics 173 cytology 297 BFU-E 119 blood delivery 397 cell count 23 / diabetes mellitus 103 count 155 diagnosis 173 donors 317 discordant lymphoma 139 (Issue 2)* transfusion 391 drug therapy 125 marrow 297 drug-induced 307 6-thalassaemia 373 dry gangrene 65 cardiac toxicity 197 dyserythropoietic 7 catheter-related bacteraemia 187 dysplastic changes 297 CD34 + cells 231 CD45-Pecy5 385 economic 301 CD55 8] economical evaluation 355 CD59 8] EDTA-induced 193 central venous catheter 187 elderly subjects 297 ELISA 313 Due to a pagination numbering error in this volume, two articles eosinophil 33 ‘Concomitant angioimmunoblastic T-cell lymphoma and low grade 3-cell lymphoproliferative disorder’ by C. Christopoulos, A. Tassidou, erythrocyte S. Golfinopoulou, G. \nastasiadis, S. Manetas & D. Anagnostou adhesiveness/ag gregation 21] (Issue 2) and ‘Molecular abnormalities in B-cell chronic lymphocytic deformability 1( ) 22 leukaemia’ by C. Fegan (Issue 3) begin on page 139. As a result all sedimentation rate 2] associated keywords in the subject index and the entries in the author index related to these papers have been labelled Issue 2 or Issue 3 to erythrocytes 7 identify their source. indices 7 2001 Blackwell Science Limited Subject Inc lex to Volume 23 erythropoiesis 71, 271, 291 immunophenotyping 81 erythropoietin 1, 71, 291 immunoturbidimetric 313 inherited bleeding disorder 209 INR 189 IRF 27 reticulocytes 149 iron 1 factor deficiency 201 factor V Leiden 261] Jamaica 285 filterability 103 fingertip 155 kanamycin 193 FLAG-Ida 135 karyotype 139 (Issue 3)’ flow cytometry 43, 97, 167, 149, folate 161 L-Arginine 131 L-Arginine: nitric oxide pathway 131 genotype 325 late relapse 197 gestational hypertension 131 leucodepletion 43 glycoproteinV 307 leukopenia 193 glycosylated haemoglobin 103 Liatest™ antithrombin III 313 GPI-anchored proteins 8] low molecular weight heparin 301 lung 361 lymphoma 119, 197 haematocrit 155, 361 haematological malignancy 187 mass spectrometry 407 haematology 285 MDS-RAEB 255 haematology analyser 155 mean cell fluorescence 385 haemoglobin 155 mean corpuscular volume 361 folate 15 mean platelet component 181 H disease 325 melphalan 125 379 methylmalonic acid 161 F 149, 285 mini-allograft 135 Q-Thailand 53 molecular biology 209 haemoglobinopathy 53 MRI 57 haemoglobinuria 9] MRSA 329 haemolysis 53 multiple myeloma 125 haemophilia 201 mutations 373 haemopoietic progenitor cells 231 myelodysplasia 249 haemopoietic stem cell transplantation 125 hairy cell leukaemia 385 neutropenia 39 hearing loss 57 neutrophils 111, 193, 243 heparin-induced thrombocytopenia 261 newborn position 397 hepatitis C virus 317 non-immune chronic idiopathic neutropenia syndrome hereditary 7 (NI-CINS) 111] spherocytosis 53 high affinity haemoglobin 407 off-site sampling 189 high-dose methylprednisolone 33 outpatient treatment 301 homocysteine 16] ozone 243 2 hydroxyurea 149, 259 hyperdiploid 255 P53 139 (Issue 3)’ PA-IgG 307 immunoglobulin gene rearrangement 139 (Issue 2)” parameters 271 immunophenotype 33, 173 paroxysmal nocturnal haemoglobinuria 81 2001 Blackwell Science Ltd., Clin. Lab. Haem., 23 425-427 Subject Index to Volume 23 Ca | pathophysiology 71 secondary 271 patient outcomes 301 serum folate 15 PCR 373, 401 serum pro-inflammatory cytokines 111 peripheral blood stem cells 119, 231 severity 285 transplantation 197 SGPT 317 PFA-100™ 131 SIADH 255 3 phenotype 325 sickle cell 285 physiology 71 disease 329 plasma haemoglobin 91 haemoglobin 379 platelet aggregation 131 skin necrosis 261 platelets 181 soluble pregnancy 131, 16] cell adhesion molecules 111 prevalence 317 transferrin receptor 291 primary thrombocythaemia 259 spherocytosis 249 prophylaxis 39 splenomegaly 111 protein S deficiency 261 standardization 43 prothrombin time inhibition 61 steroid 33 PT 189 storage 189 pulmonary disease 27 stored blood haemolysis 91 pyomyositis 329 STR analysis 401 superoxide 243 quality control 43 Sysmex” quantification 167 RAM-1 97 SE-9500 231 recombinant thromboplastin 61 red blood cell fragmentation 167 T-cell receptor gene rearrangement 139 (Issue 2)* red cell 361 thrombocytopenia 181 folate 15 thrombocytosis 65 reference transcobalamin 365 range/s 181, 297 transformation 259 values 29] translocation (4; 6) 259 relapse 173 transplantation 401 relapsed AML, 135 treatment 57 relative polycythaemia 407 reliability 189 umbilical cord blood renal failure 365 resistance 39 validity 167 to activated protein C 411 varicella-zoster 253 respiration 361 venous 155 reticulocyte count 97 thromboembolism reticulocytes 7, 27, 355 thrombosis 187 review 71, 271 viscoelastic properties 103 Rituximab 253 vitamin B,> 161 routine blood picture 155 von Willebrand Russel viper venom time 411 disease 209 factor 209 screening tests 379 SE-9500 237 whole blood 391 SEA deletion 325 second allograft 135 XE-2100 167 2001 Blackwell Science Ltd., Clin. Lab. Haem., 23, 425-427